Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST
मुख्य लेखकों: | , , , , , , , , , , |
---|---|
स्वरूप: | Conference item |
प्रकाशित: |
American Thoracic Society
2018
|